Integrated BioPharma, Inc.: Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020
HILLSIDE, NJ / ACCESSWIRE / February 12, 2021 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the Company or INBP ) reports its financial results for the quarter ended December 31, 2020.
Revenue for the quarter ended December 31, 2020 was $14.3 million compared to $14.2 million for the quarter ended December 31, 2019, an increase of $0.1 million or 0.7%. The Company had operating income for each of the quarters ended December 31, 2020 and 2019 of $1.2 million.
Revenues for the six-month period ended December 31, 2020 were $29.4 million compared to $25.6 million for the six-month period ended December 31, 2019, an increase of $3.8 million or 14.8%. The Company had operating income for the six-month period ended December 31, 2020 of $2.8 million compared to operating income of $1.7 million for the six-month period ended December 31, 2019.
NEWS that Jenners, once renowned as “the Harrods of the North”, is to close in May, has left many of its customers bereft. Not that it comes as any great shock. In recent years, while run by House of Fraser, it has been painful to visit, with its warren of shabby corridors, groaning lifts that never seemed to arrive, and its stock on almost permanent reduction. In its prime, however, Jenners was the foremost department store in the capital, a byword for class and style. Its heyday lasted for well over 150 years, from its founding in 1838 by Charles Jenners and Charles Kennington. The prospect of Edinburgh without Jenners is like Paris without the Eiffel Tower. On May 3, when the tills go silent, the city will bid farewell to its most lustrous store and the memories it holds.